117 related articles for article (PubMed ID: 12552336)
1. Diagnostic and prognostic value of 99mTc-tetrofosmin scintigraphy in maxillofacial flaps.
Aigner RM; Schultes G; Sorantin E
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):197-201. PubMed ID: 12552336
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET: early postoperative period of oro-maxillo-facial flaps.
Aigner RM; Schultes G; Wolf G; Yamashita Y; Sorantin E; Kärcher H
Nuklearmedizin; 2003 Oct; 42(5):210-4. PubMed ID: 14571317
[TBL] [Abstract][Full Text] [Related]
3. A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions.
Obwegeser R; Berghammer P; Rodrigues M; Granegger S; Hohlagschwandtner M; Kucera H; Singer C; Berger A; Kubista E; Sinzinger H
Eur J Nucl Med; 1999 Dec; 26(12):1553-9. PubMed ID: 10638406
[TBL] [Abstract][Full Text] [Related]
4. Detection of axillary lymph node metastases in breast cancer with Tc-99m tetrofosmin scintigraphy.
Schillaci O; Scopinaro F; Spanu A; Donnetti M; Danieli R; Di Luzio E; Madeddu G; David V
Int J Oncol; 2002 Mar; 20(3):483-7. PubMed ID: 11836558
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
6. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
8. The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors.
Yapar Z; Kibar M; Yapar AF; Uguz A; Ozbarlas S; Gonlusen G
Ann Nucl Med; 2003 Sep; 17(6):443-9. PubMed ID: 14575377
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
10. Review of monitoring free muscle flap transfers in reconstructive surgery: role of 99mTc sestamibi scintigraphy.
Top H; Sarikaya A; Aygit AC; Benlier E; Kiyak M
Nucl Med Commun; 2006 Jan; 27(1):91-8. PubMed ID: 16340728
[TBL] [Abstract][Full Text] [Related]
11. [COMPARISON OF REPAIR EFFECT BETWEEN CHIMERIC ANTEROLATERAL THIGH FLAP AND SERIES-WOUND FLAPS FOR DEFECT AFTER RESECTION OF ORAL AND MAXILLOFACIAL CANCER].
Yang H; Zhang H; Chen H; Yang S; Wang J; Hu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Apr; 30(4):447-52. PubMed ID: 27411273
[TBL] [Abstract][Full Text] [Related]
12. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-tetrofosmin scintigraphy in musculoskeletal tumours: the relationship between P-glycoprotein expression and tetrofosmin uptake in malignant lesions.
Yapar Z; Kibar M; Ozbarlas S; Yapar AF; Uguz A; Zorludemir S; Herdem M
Nucl Med Commun; 2002 Oct; 23(10):991-1000. PubMed ID: 12352598
[TBL] [Abstract][Full Text] [Related]
14. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
[TBL] [Abstract][Full Text] [Related]
15. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease.
Galassi AR; Azzarelli S; Tomaselli A; Giosofatto R; Ragusa A; Musumeci S; Tamburino C; Giuffrida G
Am J Cardiol; 2001 Jul; 88(2):101-6. PubMed ID: 11448403
[TBL] [Abstract][Full Text] [Related]
16. [Semiquantification of pulmonary and hepatic uptake of technetium-99m-tetrofosmin in myocardial perfusion imaging using multiple regions of interest. Multifactorial correlation].
Zafirakis A; Koutsikos I; Velidaki A; Mablekos G
Hell J Nucl Med; 2007; 10(2):129-37. PubMed ID: 17684594
[TBL] [Abstract][Full Text] [Related]
17. The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer.
Fattori B; Grosso M; Nacci A; Bianchi F; Cosottini M; Ursino F; Manca G; Rubello D; Strauss HW; Mariani G
Cancer Biother Radiopharm; 2005 Feb; 20(1):27-35. PubMed ID: 15778576
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
[TBL] [Abstract][Full Text] [Related]
20. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]